Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cell wall of Mycobacterium tuberculosis (Mtb) is a complex, multilayered structure essential for bacterial survival, virulence, and resistance to antibiotics. The synthesis of this cell wall involves several key enzymes that are critical drug targets due to their essential roles in building and maintaining the unique architecture of the Mtb envelope. These enzymes participate in the biosynthesis of major cell wall components: peptidoglycan, arabinogalactan, and mycolic acids. Key enzymes include PonA1, PonA2, LdtB, DprE1, Culp6, and RmlA-RmlD. Targeting these enzymes is a major strategy for anti-tubercular drug development.
Inhibition of cell wall biosynthesis
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis Cell Wall Synthesis Enzymes (Mtb Cell Wall Enzymes).